Comstock Metals Ltd. (CVE:CSL), a gold junior, jumped after announcing drill results from its Preview SW gold project in Saskatchewan
Sean Mason | May 8, 2017 | SmallCapPower
Near-surface drill results sparked a bit of speculation in a gold junior Monday. Here’s some small stocks making big moves on Monday, May 8, 2017 (as of 4 pm EST):
Comstock Metals Ltd. (TSXV: CSL) shares gained 11% to $0.155 on Monday after the gold junior announced initial results from the winter diamond drilling program at its 100% owned Preview SW gold project in Saskatchewan, which included 17.98 g/t gold over 5.71 metres starting at 10 metres below surface.
As well, shares of AGT Food and Ingredients Inc. (TSX: AGT) slipped 13% to $26.38 as the processor of value-added pulses, staple foods and ingredients said its first-quarter results were “weak in terms of our earnings,” and warned that near-term headwinds caused by non-tariff trade barriers and slower seasonal sales in certain markets like India and Turkey are expected to continue in the near term.
Oncolytics Biotech Inc. (TSX: ONC), meanwhile, reported that the United States Food and Drug Administration (FDA) has granted Fast Track designation for REOLYSIN, the Company’s immuno-oncology viral agent for the treatment of metastatic breast cancer. Oncolytics Biotech stock moved up 20% to $0.91 following the announcement.
Finally, Dalradian Resources Inc. (TSX: DNA) shares climbed 11% to $1.30 after the gold explorer/project developer announced results from the processing of nearly 14,500 tonnes of mineralized material from its Curraghinalt gold project in Northern Ireland. Milling resulted in a positive reconciliation for the test stopes, yielding 42% more ounces and a 40% higher grade compared with the Block Model of the 2016 NI 43-101 Mineral Resource Estimate.
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
Disclosure: Neither the author nor any of the principals at Small Cap Power, or their family members, own shares in any of the companies mentioned above.
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below:
